# Leadership, Planning and Evaluation

> **NIH NIH P30** · UNIVERSITY OF NEBRASKA MEDICAL CENTER · 2021 · $473,657

## Abstract

PROJECT SUMMARY: LEADERSHIP PLANNING AND EVALUATION
The Fred & Pamela Buffett Cancer Center (BCC) will continue to leverage strong leadership and effective
planning processes, internal and external advisors, university and hospital leaders, and community partners,
to strengthen and advance innovative scientific and clinical research, promote transdisciplinary collaborations
integrated with cancer care, strengthen and expand cancer training and educational programs for trainees and
faculty, and expand community outreach and engagement with diverse community partners across the state.
Important accomplishments since the last review include the opening of the new BCC ($350 M 615,000 sq ft)
Integrated Cancer Research and Cancer Care Facility, which resulted in expansion and consolidation of
research space. The BCC Director now has authority over 400,000 sq ft space for research, which represents
a 67% increase since the last review and 3.3-fold increase since 1999. During this funding period, the BCC
organization was strengthened with the Director now reporting directly to both the UNMC Chancellor and the
Nebraska Medicine CEO, and serving as the BCC Physician-in-Chief, ensuring oversight over cancer research
and clinical programs across the university and the healthcare network. Since the last review, the BCC has
recruited Ray Bergan as BCC Deputy Director and added a new position as Associate Director for Community
Outreach and Engagement. In addition, three new leaders were appointed since 2015 including the Associate
Director Basic Research, Associate Director Translational Research, and Associate Director Training and
Education. To continue to achieve advances envisioned by the leadership, the BCC will: 1) expand support for
recruitment and development of key priority areas of scientific focus; 2) increase research that addresses the
cancer burden and disparities in our catchment area (Nebraska); 3) develop an organization committed to
interdisciplinary, collaborative translational research; and 4) expand training and education and externally
funded programs with an emphasis on diversity. Evaluation is a priority and is used to ensure that resources
are aligned with priorities. Progress is reviewed throughout the year, with a comprehensive review annually, the
latter in particular serving as a foundation to assess progress and revise strategies. This includes evaluations
by Members of all Shared Resources, and key activities, such as those managed through the Clinical Trial
Office. Progress in Community Outreach and Engagement is reviewed with the COE Community Advisory
Board and Internal Advisory Board quarterly. The BCC will continue to receive input from its External Advisory
Board annually and throughout the year as needed. The BCC will leverage institutional leadership and
resources, and will engage key stakeholders in support of its aims to: 1) develop a strong senior leadership for
establishing the BCC vision and goals; 2) advance effecti...

## Key facts

- **NIH application ID:** 10270907
- **Project number:** 2P30CA036727-35
- **Recipient organization:** UNIVERSITY OF NEBRASKA MEDICAL CENTER
- **Principal Investigator:** KENNETH H. COWAN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $473,657
- **Award type:** 2
- **Project period:** 1997-09-05 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10270907

## Citation

> US National Institutes of Health, RePORTER application 10270907, Leadership, Planning and Evaluation (2P30CA036727-35). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10270907. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*